ICAR 2020 VIRTUAL MEETING UPDATE
Many of our Society members and speakers are working tirelessly to respond to the COVID-19 pandemic, whether it be in drug discovery, vaccine development, clinical care, policy development or other activities. Additionally, all of us are working to respond to changes in our personal lives. With all of the ongoing demands on our efforts and expertise, we realize that though exchange of research and new ideas that comes with a conference is very important, the priority right now needs to be on COVID-19 response. We have therefore decided to postpone the virtual ICAR2020 until late summer or early fall. The date will be decided by the ISAR Board of Directors, based on their assessment of the situation and the timing of other major conferences. Paid registration will carry forward to the rescheduled meeting. You will be informed of any new developments.
We hope that you and your family remain safe and that you are able to work productively during this challenging time.
Johan Neyts and Kara Carter
President and President-Elect, ISAR
The 33rd International Conference on Antiviral Research (ICAR), hosted by the International Society for Antiviral Research (ISAR), will be a virtual conference with more details to come soon.
Join the ISAR mailing list to receive email announcements and updates on the Society and the International Conference on Antiviral Research (ICAR).